Skip to main
DHR

Danaher (DHR) Stock Forecast & Price Target

Danaher (DHR) Analyst Ratings

Based on 18 analyst ratings
Buy
Strong Buy 44%
Buy 39%
Hold 17%
Sell 0%
Strong Sell 0%

Bulls say

Danaher is a diversified manufacturing company with a focus on scientific instruments and consumables in the life sciences and diagnostics industries. Its recent divestiture of its environmental and applied solutions group allows the company to focus on its core business and positions it for future growth. The company's strong financial performance, including solid revenue growth and improving margins, combined with its strategic initiatives, make it an attractive investment opportunity. Additionally, Danaher's strong leadership team and commitment to sustainability and diversity are positive indicators for the company's long-term success.

Bears say

Danaher is a manufacturer and seller of scientific instruments and consumables to various industries globally. The company's recent divestiture of its environmental and applied solutions group, Veralto, has focused its business on the life sciences and diagnostic industries. However, concerns about the growth of its bioprocess equipment and diagnostics markets, as well as the company's recent acquisition strategy, contribute to the negative outlook. Additionally, the company operates in highly regulated industries and has a history of selling or divesting certain business lines, leading to potential volatility in its revenue and earnings.

Danaher (DHR) has been analyzed by 18 analysts, with a consensus rating of Buy. 44% of analysts recommend a Strong Buy, 39% recommend Buy, 17% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Danaher and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Danaher (DHR) Forecast

Analysts have given Danaher (DHR) a Buy based on their latest research and market trends.

According to 18 analysts, Danaher (DHR) has a Buy consensus rating as of Jun 17, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $237.06, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $237.06, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Danaher (DHR)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.